Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...
Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis with improved efficiency and ease of use.
Even when within the normal range, lower levels of vitamin B12 may contribute to cognitive decline, according to a new study.
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...
Immunology is the branch of biomedical sciences concerned with all aspects of the immune system in all multicellular organisms. Through comprehensive genomic and immune analyses, mechanisms of ...
Immunology and Inflammation DGKα and ζ Deficiency Causes Regulatory T-Cell Dysregulation, Destabilization, and Conversion to Pathogenic T-Follicular Helper Cells to Trigger IgG1-Predominant ...
In the final episode, experts at UCSD and La Jolla Institute discuss current clinical trials of a cancer vaccine and future directions for neoantigen vaccines. Custom-made Cancer Therapy ...
A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...
Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #aptima--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k ...
Esoteric Testing Market Research Report In 2022, the global esoteric testing market was valued at $24.2 billion and projected reach $68.5 b ...
There are a number of limitations to the current study. A power calculation was not performed prior to beginning data collection. The decision to include 50 patients in each arm was based on ...